JP2013542179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542179A5 JP2013542179A5 JP2013527063A JP2013527063A JP2013542179A5 JP 2013542179 A5 JP2013542179 A5 JP 2013542179A5 JP 2013527063 A JP2013527063 A JP 2013527063A JP 2013527063 A JP2013527063 A JP 2013527063A JP 2013542179 A5 JP2013542179 A5 JP 2013542179A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- tgf
- antibody
- seq
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37931510P | 2010-09-01 | 2010-09-01 | |
| US61/379,315 | 2010-09-01 | ||
| PCT/US2011/001536 WO2012030394A1 (en) | 2010-09-01 | 2011-09-01 | Treatment of myocardial infarction using tgf - beta antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017083499A Division JP2017193543A (ja) | 2010-09-01 | 2017-04-20 | ＴＧＦ−βアンタゴニストを使用する心筋梗塞の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542179A JP2013542179A (ja) | 2013-11-21 |
| JP2013542179A5 true JP2013542179A5 (https=) | 2014-10-09 |
| JP6377348B2 JP6377348B2 (ja) | 2018-08-22 |
Family
ID=44654454
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013527063A Expired - Fee Related JP6377348B2 (ja) | 2010-09-01 | 2011-09-01 | ＴＧＦ−βアンタゴニストを使用する心筋梗塞の処置 |
| JP2017083499A Pending JP2017193543A (ja) | 2010-09-01 | 2017-04-20 | ＴＧＦ−βアンタゴニストを使用する心筋梗塞の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017083499A Pending JP2017193543A (ja) | 2010-09-01 | 2017-04-20 | ＴＧＦ−βアンタゴニストを使用する心筋梗塞の処置 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20130330352A1 (https=) |
| EP (1) | EP2611831B1 (https=) |
| JP (2) | JP6377348B2 (https=) |
| KR (1) | KR101939965B1 (https=) |
| CN (1) | CN103201292B (https=) |
| BR (1) | BR112013004850B1 (https=) |
| CA (1) | CA2809568C (https=) |
| CL (1) | CL2013000586A1 (https=) |
| ES (1) | ES2715177T3 (https=) |
| IL (1) | IL225018A (https=) |
| MX (1) | MX354535B (https=) |
| MY (1) | MY165160A (https=) |
| NZ (2) | NZ608813A (https=) |
| PH (1) | PH12013500411A1 (https=) |
| PL (1) | PL2611831T3 (https=) |
| RU (1) | RU2637088C2 (https=) |
| SG (2) | SG187953A1 (https=) |
| TR (1) | TR201903101T4 (https=) |
| WO (1) | WO2012030394A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1008628A2 (pt) * | 2009-02-18 | 2016-03-01 | Cormatrix Cardiovascular Inc | método de tratamento ou prevenção de arritmia cardíaca em um indivíduo |
| PT2971048T (pt) * | 2013-03-11 | 2019-02-06 | Genzyme Corp | Anticorpos anti-tgf-beta manipulados e fragmentos de ligação a antigénios |
| CA2921805C (en) | 2013-08-22 | 2023-03-07 | Acceleron Pharma, Inc. | Tgf-beta receptor type ii variants and uses thereof |
| EP3234120B1 (en) | 2014-12-15 | 2025-09-03 | The Regents of the University of California | Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing |
| EP4400516A1 (en) | 2014-12-15 | 2024-07-17 | The Regents of the University of California | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 |
| HK1256638A1 (zh) | 2015-08-04 | 2019-09-27 | Acceleron Pharma Inc. | 用於治疗骨髓增生性病症的方法 |
| DK3368571T5 (da) | 2015-10-30 | 2024-09-30 | Univ California | Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf |
| TW201726744A (zh) | 2016-01-11 | 2017-08-01 | 奧托德里克有限公司 | 用於檢測奧美沙坦(olmesartan)及改善治療高血壓之遵從性的組成物、裝置及方法 |
| US20170218040A1 (en) * | 2016-02-02 | 2017-08-03 | Julio A. Camarero Palao | Proteolically resistant cyclotides with angiotensin 1-7 like activity |
| JP2019533003A (ja) * | 2016-08-11 | 2019-11-14 | プレシセラ，インコーポレイテッド | ＴＧＦ−βアンタゴニストコンジュゲート |
| LT3628049T (lt) | 2017-05-04 | 2023-08-25 | Acceleron Pharma Inc. | Tgf-beta ii tipo receptoriaus sulieti baltymai ir jų panaudojimo būdai |
| AU2021339468A1 (en) * | 2020-09-10 | 2023-03-30 | Implicit Bioscience Limited | Therapeutic methods and agents for the treatment of myocardial infarction |
| US20250034212A1 (en) | 2021-09-30 | 2025-01-30 | Peptidream Inc. | Peptide |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5571714A (en) | 1988-12-22 | 1996-11-05 | Celtrix Pharmaceuticals, Inc. | Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| DE69941267D1 (de) | 1998-12-10 | 2009-09-24 | Bristol Myers Squibb Co | Proteingerüste für antikörper-nachahmer und andere bindende proteine |
| US7763580B2 (en) * | 1999-01-05 | 2010-07-27 | University Of Utah Research Foundation | Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| CN1961003B (zh) * | 2004-03-31 | 2013-03-27 | 健泰科生物技术公司 | 人源化抗TGF-β抗体 |
| WO2006083779A2 (en) | 2005-01-31 | 2006-08-10 | Mylan Laboratories, Inc. | Pharmaceutical composition comprising hydroxylated nebivolol |
| WO2006086469A2 (en) * | 2005-02-08 | 2006-08-17 | Genzyme Corporation | Antibodies to tgfbeta |
| AU2010206543A1 (en) * | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
| ITMI20110376A1 (it) | 2011-03-10 | 2012-09-11 | Wilic Sarl | Aerogeneratore raffreddato a fluido |
-
2011
- 2011-09-01 MY MYPI2013000675A patent/MY165160A/en unknown
- 2011-09-01 NZ NZ608813A patent/NZ608813A/en not_active IP Right Cessation
- 2011-09-01 CN CN201180052346.0A patent/CN103201292B/zh not_active Expired - Fee Related
- 2011-09-01 WO PCT/US2011/001536 patent/WO2012030394A1/en not_active Ceased
- 2011-09-01 EP EP11758276.7A patent/EP2611831B1/en active Active
- 2011-09-01 PH PH1/2013/500411A patent/PH12013500411A1/en unknown
- 2011-09-01 MX MX2013002390A patent/MX354535B/es active IP Right Grant
- 2011-09-01 CA CA2809568A patent/CA2809568C/en not_active Expired - Fee Related
- 2011-09-01 TR TR2019/03101T patent/TR201903101T4/tr unknown
- 2011-09-01 US US13/819,393 patent/US20130330352A1/en not_active Abandoned
- 2011-09-01 RU RU2013114365A patent/RU2637088C2/ru active
- 2011-09-01 SG SG2013013875A patent/SG187953A1/en unknown
- 2011-09-01 NZ NZ624382A patent/NZ624382A/en not_active IP Right Cessation
- 2011-09-01 KR KR1020137008326A patent/KR101939965B1/ko not_active Expired - Fee Related
- 2011-09-01 ES ES11758276T patent/ES2715177T3/es active Active
- 2011-09-01 BR BR112013004850A patent/BR112013004850B1/pt not_active IP Right Cessation
- 2011-09-01 PL PL11758276T patent/PL2611831T3/pl unknown
- 2011-09-01 JP JP2013527063A patent/JP6377348B2/ja not_active Expired - Fee Related
- 2011-09-01 SG SG10201506909PA patent/SG10201506909PA/en unknown
-
2013
- 2013-02-28 CL CL2013000586A patent/CL2013000586A1/es unknown
- 2013-02-28 IL IL225018A patent/IL225018A/en active IP Right Grant
-
2016
- 2016-12-12 US US15/376,358 patent/US10633437B2/en not_active Expired - Fee Related
-
2017
- 2017-04-20 JP JP2017083499A patent/JP2017193543A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542179A5 (https=) | ||
| RU2013114365A (ru) | Лечение инфаркта миокарда с использованием антагонистов tgf-бета | |
| ES2985986T3 (es) | Conjugado biciclo para tratar el cáncer | |
| JP2022528887A (ja) | バイシクルトキシンコンジュゲートおよびその使用 | |
| US20240254120A1 (en) | Ep4 inhibitors and synthesis thereof | |
| JP2014533279A5 (https=) | ||
| JP2009518441A5 (https=) | ||
| EP3365368A1 (en) | Tgfbeta1-binding immunoglobulins and use thereof | |
| AU2019210332A1 (en) | Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cells | |
| CN116059218A (zh) | 一种使用免疫调节治疗癌症的新颖方法 | |
| TW202005985A (zh) | 用雙特異性抗ＣＤ３ｘＭＵＣ１６抗體及抗ＰＤ－１抗體治療癌症的方法 | |
| JP2012102122A5 (https=) | ||
| US20240358723A1 (en) | Polymorphic compounds and uses thereof | |
| EP3781162A1 (en) | Ep4 inhibitors and use thereof | |
| KR20160133479A (ko) | 자가면역 질환의 치료를 위한 조합 요법 | |
| EP4041394A1 (en) | Use of high-affinity, ligand-blocking, humanized anti-t-cell immunoglobulin domain and mucin domain-3 (tim-3) igg4 antibody for the treatment of myelofibrosis | |
| US20220025061A1 (en) | Combination therapies for treating disease using an innate immunity modifier and an ox40 agonist | |
| US20220062250A1 (en) | Combination of a sk2 inhibitor and an inhibitor of a checkpoint pathway, uses and pharmaceutical compositions thereof | |
| CN101455675A (zh) | 具有肾保护作用的阿魏酸和黄芪甲苷组合物及其制备方法和用途 | |
| AU2024277733A1 (en) | Methods of treating cancer with anti-mica/b antibodies | |
| KR20200020918A (ko) | 암 수술 후의 재발 및/또는 전이 억제제 | |
| EA048751B1 (ru) | TGFβ1-СВЯЗЫВАЮЩИЕ ИММУНОГЛОБУЛИНЫ И ИХ ПРИМЕНЕНИЕ |